1,723
Views
82
CrossRef citations to date
0
Altmetric
Research Article

Structural MRI Findings in Long-Term Cannabis Users: What Do We Know?

, , , &
Pages 1787-1808 | Published online: 30 Jun 2010

References

  • Arnone, D., Barrick, T. R., Chengappa, S., Mackay, C. E., Clark, C. A., Abou-Saleh, M. T. (2008). Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. NeuroImage, 41(3):1067–1074.
  • Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., Moffitt, T. E. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal, 325(7374):1212–1213.
  • Block, R. I., O’Leary, D. S., Ehrhardt, J. C., Augustinack, J. C., Ghoneim, M. M., Arndt, S., (2000). Effects of frequent marijuana use on brain tissue volume and composition. NeuroReport, 11(3):491–496.
  • Block, R. I., O’Leary, D. S., Hichwa, R. D., Augustinack, J. C., Boles Ponto, L. L., Ghoneim, M. M., (2002). Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacology, Biochemistry and Behavior, 72(1–2):237–50.
  • Bolla, K. I., Brown, K., Eldreth, D., Tate, K., Cadet, J. L. (2002). Dose-related neurocognitive effects of marijuana use. Neurology, 59(9):1337–1343.
  • Bolla, K. I., Eldreth, D. A., Matochik, J. A., Cadet, J. L. (2005). Neural substrates of faulty decision-making in abstinent marijuana users. NeuroImage, 26(2):480–492.
  • Campbell, A. M. G., Evans, M., Thomson, J. L. G., Williams, M. J. (1971). Cerebral atrophy in young cannabis smokers. The Lancet, 2(7736):1219–1224.
  • Chan, G. C. K., Hinds, T. R., Impey, S., Storm, D. R. (1998). Hippocampal neurotoxicity of Δ9−Tetrahydrocannabinol. The Journal of Neuroscience, 18(14):5322–5332.
  • Chang, L., Chronicle, E. P. (2007). Functional imaging studies in cannabis users. Neuroscientist, 13(5):422–432.
  • Co, B. T., Goodwin, D. W., Gado, M., Mickhael, M., Hill, S. Y. (1977). Absence of cerebral atrophy in chronic cannabis users: evaluation by computerized transaxial tomography. The Journal of the American Medical Association, 237(12):1229–1230.
  • Cohen, M., Solowij, N., Carr, V. (2008). Cannabis, cannabinoids and schizophrenia: integration of the evidence. Australian and New Zealand Journal of Psychiatry, 42(5):357–368.
  • De Bellis, M. D., Clark, D. B., Beers, S. R., Soloff, P. H., Boring, A. M., Hall, J., (2000). Hippocampal volume in adolescent-onset alcohol use disorders. American Journal of Psychiatry, 157(5):737–744.
  • De Bellis, M. D., Van Voorhees, E., Hooper, S. R., Gibler, N., Nelson, L., Hege, S. G., (2008). Diffusion tensor measures of the corpus callosum in adolescents with adolescent onset alcohol use disorders. Alcoholism, Clinical and Experimental Research, 32(3):395–404.
  • Degenhardt, L., Hall, W., Lynskey, M. (2003). Exploring the association between cannabis use and depression. Addiction, 98:1493–1504.
  • DeLisi, L. E. (2008). The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? Current Opinion in Psychiatry, 21(2):140–150.
  • DeLisi, L. E., Bertisch, H. C., Szulc, K. U., Majcher, M., Brown, K., Bappal, A., (2006). A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduction Journal, 3(17).
  • Dorard, G., Berthoz, S., Phan, O., Corcos, M., Bungener, C. (2008). Affect dysregulation in cannabis abusers: a study in adolescents and young adults. European Child and Adolescent Psychiatry, 17(5):274–282.
  • Downer, E., Boland, B., Fogarty, M., Campbell, V. C. A. (2001). [DELTA]9-Tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurons via activation of the CB1 receptor. Neuroreport, 12(18):3973–3978.
  • Ehrenreich, H., Rinn, T., Kunert, H. J., Moeller, M. R., Poser, W., Schilling, L., (1999). Specific attentional dysfunction in adults following early start of cannabis use. Psychopharmacology (Berl), 142(3):295–301.
  • Eldreth, D. A., Matochik, J. A., Cadet, J. L., Bolla, K. I. (2004). Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. NeuroImage, 23(3):914–920.
  • Elkashef, A., Vocci, F., Huestis, M., Haney, M., Budney, A., Gruber, A., (2008). Marijuana neurobiology and treatment. Substance Abuse, 29(3):17–29.
  • Fornito, A., Whittle, S., Wood, S., Velakoulis, D., Pantelis, C., Yücel, M. (2006). The influence of sulcal variability on morphometry of the human anterior cingulate and paracingulate cortex. NeuroImage, 33:843–854.
  • Fornito, A., Wood, S. J., Whittle, S., Fuller, J., Adamson, C., Saling, M. M., (2008). Variability of the paracingulate sulcus and morphometry of the medial frontal cortex: associations with cortical thickness, surface area, volume, and sulcal depth. Human Brain Mapping, 29(2):222–236.
  • Fried, P., Watkinson, B., James, D., Gray, R. (2002). Current and former marijuana use: preliminary findings of a longitudinal study of effects on IQ in young adults. CMAJ: Canadian Medical Association Journal, 166(7):887.
  • Gaoni, Y., Mechoulam, R. (1971). The isolation and structure of delta-1-tetrahydrocannabinol and other neutral cannabinoids from hashish. Journal of the American Chemical Society, 93(1):217–224.
  • Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., (1999). Brain development during childhood and adolescence: a longitudinal MRI study. Nature Neuroscience, 2(10):861–863.
  • Gonzalez, R., Carey, C., Grant, I. (2002). Nonacute (residual) neuropsychological effects of cannabis use: a qualitative analysis and systematic review. Journal of Clinical Pharmacology, 42(11 Suppl.):48S–57S.
  • Gruber, S. A., Yurgelun-Todd, D. A. (2005). Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation. Brain Research. Cognitive Brain Research, 23:107–118.
  • Hannerz, J., Hindmarsh, T. (1983). Neurological and neuroradiological examination of chronic cannabis smokers. Annals of Neurology, 13(2):207–210.
  • Harper, J. W., Heath, R. G., Myers, W. A. (1977). Effects of Cannabis sativa on ultrastructure of the synapse in monkey brain. Journal of Neuroscience Research, 3(2):87–93.
  • Heath, R. G., Fitzjarrell, A. T., Fontana, C. J., Garey, R. E. (1980). Cannabis sativa: effects on brain function and ultrastructure in rhesus monkeys. Biological Psychiatry, 15(5):657–690.
  • Hermann, D., Sartorius, A., Welzel, H., Walter, S., Skopp, G., Ende, G., (2007). Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users. Biological Psychiatry, 61(11):1281–1289.
  • Hill, A. B. (1965). The environment and disease: association or causation? Proceedings of the Royal Society of Medicine, 58:295–300.
  • Iversen, L. (2003). Cannabis and the brain. Brain, 126(6):1252–1270.
  • Jacobsen, L. K., Mencl, W. E., Westerveld, M., Pugh, K. R. (2004). Impact of Cannabis use on brain function in adolescents. Annals of the New York Academy of Sciences, 1021:384–390.
  • Jager, G., Van Hell, H. H., De Win, M. M. L., Kahn, R. S., Van Den Brink, W., Van Ree, J. M., (2007). Effects of frequent cannabis use on hippocampal activity during an associative learning memory task. European Neuropsychopharmacology, 17:289–297.
  • Johns, A. (2001). Psychiatric effects of cannabis. British Journal of Psychiatry, 178:116–122.
  • Kanayama, G., Rogowska, J., Pope, H., Gruber, S. A., Yurgelun-Todd, D. A. (2004). Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology, 176:239–247.
  • Kuehnle, J., Mendelson, J. H., Davis, K. R., New, P. F. (1977). Computed tomographic examination of heavy marijuana smokers. The Journal of the American Medical Association, 237(12):1231–1232.
  • Landfield, P. W., Caldwallader, L. B., Vinsant, S. (1988). Quantitative changes in hippocampal structure following long-term exposure to Δ9-tetrahydrocannabinol: possible mediation by glucocorticoid systems. Brain Research, 443(1–2):47–62.
  • Lange, N., Giedd, J. N., Castellanos, F. X., Vaituzis, A. C., Rapaport, J. L. (1997). Variability of human brain structure size: ages 4–20 years. Psychiatry Research: Neuroimaging Section, 74:1–12.
  • Lawstone, J., Borella, A., Robinson, J. K., Whitaker-Azmitia, P. M. (2000). Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212–2. Brain Research, 877:407–410.
  • Lubman, D. I., Yucel, M., Hall, W. D. (2007). Substance use and the adolescent brain: a toxic combination? Journal of Psychopharmacology, 21(8):792–794.
  • Matochik, J. A., Eldeth, D. A., Cadet, D. A., Bolla, K. I. (2005). Altered brain tissue composition in heavy marijuana users. Drug and Alcohol Dependence, 77:23–30.
  • Medina, K. L., Nagel, B. J., Park, A., McQueeny, T., Tapert, S. F. (2007a). Depressive symptoms in adolescents: associations with white matter volume and marijuana use. Journal of Child Psychology and Psychiatry, 48(6):592–600.
  • Medina, K. L., Schweinsburg, A. D., Cohen-Zion, M., Nagel, B. J., Tapert, S. F. (2007b). Effects of alcohol and combined marijuana and alcohol use hippocampal volume and asymmetry. Neurotoxicology and Teratology, 29:141–152.
  • Meyers, W. A., III, Heath, R. G. (1979). Cannabis sativa: ultrastructural changes in organelles of neurons in brain septal region of monkeys. Journal of Neuroscience Research, 4(1):9–17.
  • Miettunen, J., Tormanen, S., Murray, G. K., Jones, P. B., Maki, P., Ebeling, H., (2008). Association of cannabis use with prodromal symptoms of psychosis in adolescence. The British Journal of Psychiatry, 192(6):470–471.
  • Moore, T. H., Zammit, S., Lingford-Huges, A., Barnes, T. R., Jones, P. B., Burke, M., (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet, 370:319–328.
  • Patton, G. C., Coffey, C., Carlin, J. B., Degenhardt, L., Lynskey, M., Hall, W. (2002). Cannabis use and mental health in young people: cohort study. (Papers). British Medical Journal, 325(7374):1195–1198.
  • Pope, H. G., Gruber, A. J., Hudson, J. I., Cohane, G., Huestis, M. A., Yurgelun-Todd, D. (2003). Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug and Alcohol Dependence, 69(3):303.
  • Pope, H. G., Jr., Gruber, A. J., Hudson, J. I., Huestis, M. A., Yurgelun-Todd, D. (2001). Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry, 58(10):909–915.
  • Pope, H. G., Jr., Yurgelun-Todd, D. (1996). The residual cognitive effects of heavy marijuana use in college students. The Journal of the American Medical Association, 275(7):521–527.
  • Quickfall, J., Crockford, D. (2006). Brain neuroimaging in cannabis use: a review. Journal of Neuropsychiatry and Clinical Neurosciences, 18(3):318–332.
  • Scallet, A. C., Uemura, E., Andrews, A., Ali, S. F., McMillan, D. E., Paule, M. G., (1987). Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC). Brain Research, 436(1):193–198.
  • Schmetzer, A. D. (2000). Book review: Cannabis and cognitive functioning, by Nadia Solowij. Cambridge University Press, Cambridge, 1998, 290 pp., $80.00. Annals of Clinical Psychiatry, 12:254–257.
  • Semple, D. M., McInsosh, A. M., Lawrie, S. M. (2005). Cannabis as a risk factor for psychosis: systematic review. Journal of Psychopharmacology, 19(2):187–194.
  • Solowij, N., Battisti, R. (2008). The chronic effects of cannabis on memory in humans: a review. Current Drug Abusers Reviews, 1(1):81–98.
  • Solowij, N., Michie, P. T. (2007). Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? Journal of Psychiatry and Neuroscience, 32(1):30–52.
  • Solowij, N., Michie, P. T., Fox, A. M. (1995). Differential impairments of selective attention due to frequency and duration of cannabis use. Biological Psychiatry, 37(10):731.
  • Solowij, N., Stephens, R., Roffman, R. A., Babor, T. (2002). Does marijuana use cause long-term cognitive deficits? The Journal of the American Medical Association, 287(20):2653–2654; author reply 2654.
  • Stefanis, C. (1976). Biological aspects of cannabis use. In R. Petersen (Ed.), The international challenge of drug abuse (pp. 149–178). Rockville, MD: National Institute on Drug Abuse.
  • Substance Abuse and Mental Health Services Administration. (2006). Results from the 2006 National Survey on Drug Use and Health: national findings. Rockville, MD: Office of Applied Studies.
  • Tisserand, D. J., Pruessner, J. C., Sanz Arigita, E. J., van Boxtel, M. P. J., Evans, A. C., Jolles, J., (2002). Regional frontal cortical volumes decrease differentially in aging: an MRI study to compare volumetric approaches and voxel-based morphometry. NeuroImage, 17(2):657–669.
  • Tzilos, G. K., Cintron, C. B., Wood, J. B. R., DSimpson, N. S., Young, A. D., Pope, H. G. J., (2005). Lack of hippocampal volume change in long-term heavy cannabis users. The American Journal on Addictions, 14:64–72.
  • Whitlow, C. T., Liguori, A., Livengood, L. B., Hart, S. L., Mussat-Whitlow, B. J., Lamborn, C. M., (2004). Long-term heavy marijuana users make costly decisions on a gambling task. Drug and Alcohol Dependence, 76(1):107–111.
  • Wilson, W., Mathew, R., Turkington, T., Hawk, T., Coleman, R. E., Provenzale, J. (2000). Brain morphological changes and early marijuana use: a MRI and PET study. Journal of Addictive Diseases, 19(1):1–22.
  • Wittchen, H. U., Frohlich, C., Behrendt, S., Gunther, A., Rehm, J., Zimmermann, P., (2007). Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug and Alcohol Dependence, 88(Suppl 1.):S60–S70.
  • Yucel, M., Lubman, D. I. (2007). Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. Drug and Alcohol Review, 26(1):33–39.
  • Yücel, M., Solowij, N., Respondek, C., Whittle, S., Fornito, A., Pantelis, C., (2008). Regional brain abnormalities associated with heavy long-term cannabis use. Archives of General Psychiatry, 65(6):1–8.
  • Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., Lewis, G. (2002). Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. British Medical Journal, 325(7374):1199.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.